Pfizer sells nutrition unit to Nestle for $11.85 billion

Article Date: 24/04/2012 07:00
Pfizer sells nutrition unit to Nestle for $11.85 billion

Vacancy Search

Quick job search

Advanced Search

Latest News

Bayer's Stivarga wins appeal to stay on CDF

Bayer's Stivarga wins appeal to stay on CDF

BMA slams seven-day GP services 'obsession'

BMA slams seven-day GP services 'obsession'

Upcoming events: a dosing decision for BioMarin, plus Roche to get Alzheimer’s data

Welcome to your weekly digest of approaching regulatory and clinical readouts. Data from BioMarin’s phase II trial of the achondroplasia project BMN 111, expected this month or next, will...

Surprise resurrection sees Aveo and Prima pining for the fjords

When it comes to dead parrots making comebacks it could not have got much more extreme than the severely depressed Aveo Oncology and Prima Biomed, whose apparently deceased oncology projects...

Novartis' Afinitor extends progression-free survival in NET

Novartis' Afinitor extends progression-free survival in NET

Regeneron/Sanofi drug improves RA symptoms in PhIII trial

Regeneron/Sanofi drug improves RA symptoms in PhIII trial

Boehringer, Eureka in intra-cellular antibodies pact

Boehringer, Eureka in intra-cellular antibodies pact

Could you be the PharmaTimes Marketer of the Year 2015?

Could you be the PharmaTimes Marketer of the Year 2015?

Novartis COPD therapies hit Phase III targets

Novartis COPD therapies hit Phase III targets

Alnylam gains on US orphan status for amyloidosis drug

Alnylam gains on US orphan status for amyloidosis drug
more news